Jan Skov Jensen

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes

Klaus Klausen, Knut Borch‐Johnsen, Bo Feldt‐Rasmussen et al. · Circulation · 2004 · 695 citations

Medicine, Internal Medicine, Nephrology +11

The Independent Effect of Type 2 Diabetes Mellitus on Ischemic Heart Disease, Stroke, and Death

Thomas Almdal, Henrik Scharling, Jan Skov Jensen et al. · Archives of Internal Medicine · 2004 · 647 citations

Medicine, Cardiology, Internal Medicine +17

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk et al. · European Heart Journal · 2011 · 546 citations · Full text

Medicine, Cardiology, Pharmacology +16

Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease

Jan Skov Jensen, Bo Feldt‐Rasmussen, Svend Strandgaard et al. · Hypertension · 2000 · 425 citations

Medicine, Cardiology, Internal Medicine +14